Rocky Mountain Advisers, LLC Omeros Corp Transaction History

Rocky Mountain Advisers, LLC

  • $120 Million
  • Q1 2025

A detailed history of Rocky Mountain Advisers, LLC transactions in Omeros Corp stock. As of the latest transaction made, Rocky Mountain Advisers, LLC holds 50 shares of OMER stock, worth $163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 1,650 96.97%
Holding current value
$163
Previous $16,000 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
SELL
$7.04 - $11.21 $11,264 - $17,936
-1,600 Reduced 96.97%
50 $0
Q3 2024

Nov 01, 2024
SELL
$3.54 - $5.47 $1,132 - $1,750
-320 Reduced 16.24%
1,650 $6,000
Q1 2024

Apr 26, 2024
SELL
$2.88 - $4.89 $71,510 - $121,418
-24,830 Reduced 92.65%
1,970 $6,000
Q4 2023

Jan 24, 2024
SELL
$1.08 - $3.63 $7,241 - $24,339
-6,705 Reduced 20.01%
26,800 $87,000
Q4 2022

Feb 01, 2023
SELL
$1.75 - $3.96 $4,812 - $10,890
-2,750 Reduced 7.59%
33,505 $76,000
Q1 2022

Apr 27, 2022
SELL
$5.07 - $7.2 $760 - $1,080
-150 Reduced 0.41%
36,255 $218,000
Q4 2021

Feb 09, 2022
BUY
$5.67 - $8.54 $83,745 - $126,135
14,770 Added 68.27%
36,405 $234,000
Q2 2021

Jul 22, 2021
BUY
$14.81 - $19.13 $40,727 - $52,607
2,750 Added 14.56%
21,635 $321,000
Q1 2021

Apr 27, 2021
BUY
$14.52 - $23.53 $24,684 - $40,001
1,700 Added 9.89%
18,885 $336,000
Q3 2020

Oct 21, 2020
SELL
$9.57 - $21.32 $478 - $1,066
-50 Reduced 0.29%
17,185 $174,000
Q2 2020

Jul 27, 2020
BUY
$12.21 - $16.99 $13,125 - $18,264
1,075 Added 6.65%
17,235 $254,000
Q1 2020

Apr 29, 2020
BUY
$9.03 - $19.72 $7,901 - $17,255
875 Added 5.72%
16,160 $216,000
Q4 2019

Jan 31, 2020
BUY
$13.01 - $17.15 $3,252 - $4,287
250 Added 1.66%
15,285 $215,000
Q2 2019

Jul 26, 2019
SELL
$15.0 - $19.62 $2,625 - $3,433
-175 Reduced 1.15%
15,035 $236,000
Q1 2019

Apr 25, 2019
BUY
$11.65 - $17.72 $28,542 - $43,414
2,450 Added 19.2%
15,210 $264,000
Q4 2018

Jan 22, 2019
BUY
$10.72 - $16.73 $10,720 - $16,730
1,000 Added 8.5%
12,760 $142,000
Q3 2018

Oct 23, 2018
BUY
$17.73 - $26.69 $4,432 - $6,672
250 Added 2.17%
11,760 $287,000
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $124,192 - $281,304
11,510 New
11,510 $209,000

Others Institutions Holding OMER

# of Institutions
153
Shares Held
28M
Call Options Held
369K
Put Options Held
697K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $205M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Rocky Mountain Advisers, LLC Portfolio

Follow Rocky Mountain Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rocky Mountain Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rocky Mountain Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email